Church & Dwight Co., Inc.
Analyzing Clorox’s Performance in the Fourth Fiscal Quarter
Clorox (CLX) reported net sales of $1.7 billion, which fell short of analysts’ expectation. However, the net sales increased 2.7% YoY.
Procter & Gamble Beats Third-Quarter Estimates
Procter & Gamble (PG) posted stronger-than-expected third-quarter results on Tuesday, April 23.
Will Colgate-Palmolive Sustain Sales Momentum in 1Q18?
Analysts expect Colgate-Palmolive (CL) to report sales of $4.0 billion in 1Q18, which represents a YoY (year-over-year) rise of 6.6%.
Clorox’s Fiscal 2Q16 Revenue Is Estimated to Be $1.3 Billion
For fiscal 2Q16, Wall Street analysts’ consensus revenue estimate for Clorox is ~$1.3 billion, a 3.4% rise from the same quarter last year.
Why SunTrust Upgraded Colgate-Palmolive Stock
On October 11, 2017, SunTrust Robinson Humphrey upgraded Colgate-Palmolive (CL) stock to a “buy” from “hold” and increased the target price.
How Much Has Colgate-Palmolive Increased Its Dividend?
Colgate-Palmolive (CL) has a market capitalization of $60.9 billion. CL rose by 0.37% to close at $68.23 per share as of March 10, 2016.
Analysts Remain Neutral on Clorox Stock before 4Q17 Results
Analysts covering Clorox (CLX) have rated the stock a 2.9 on a scale of one (strong buy) to five (strong sell) and maintain a neutral outlook.
Deutsche Bank Downgrades Church & Dwight Company to ‘Hold’
Church & Dwight (CHD) reported 3Q16 net sales of $870.7 million, a rise of 1.0% compared to net sales of $861.8 million in 3Q15.
How PG’s Valuation Compares to Peers
As of April 18, Procter & Gamble (PG) was trading at a 12-month forward PE (price-to-earnings) ratio of 22.8x.
Edgewell Increases Its Portfolio with a New Acquisition
Edgewell Personal Care Company (EPC) fell 2.8% to close at $73.87 per share during the first week of November 2016.
Key Events for Consumer Stocks: February 12–16
On February 5, Jefferies upgraded Lowe’s (LOW) to “buy” from “hold” and raised the target price to $129 from $81.
Weak Currencies, but Consumer Packaged Goods Margins Improved
The 1Q16 margins of consumer packaged goods (or CPG) companies sent strong signals. These companies have been investing heavily in innovative products and other growth initiatives.
What Could Stall the Recovery in Kimberly-Clark Stock?
Kimberly-Clark (KMB) stock has recovered nearly 6% in the last two trading days.
What’s behind Procter & Gamble’s Improving Dividend Trend?
Procter & Gamble recently announced a 4% hike in its quarterly dividend to $0.72 per share.
Why Kimberly-Clark’s Gross Margins Fell Significantly in 1Q18
Kimberly-Clark’s adjusted operating margin fell 140 basis points to 17.4%, reflecting a lower gross margin.
Clorox Disappoints on Outlook
Clorox (CLX) continued its strong top-line and bottom-line performances in fiscal 1Q18.
Why Kimberly-Clark’s EPS Could Decline in Q1 2019
Analysts expect Kimberly-Clark to post adjusted earnings of $1.54 per share in the first quarter of 2019, which implies a YoY decline of 9.9%.
What’s Behind Clorox’s Industry-Leading Sales Growth?
The Clorox Company (CLX) has managed to generate industry-leading sales despite challenges.
Why 2019 Wasn’t As Good As 2018 for Church & Dwight Stock
Although Church & Dwight stock is trading in the green, it has lagged its peers and the broader markets. The stock didn’t repeat its 2018 performance.
Procter & Gamble Stock: What’s Fueling the Growth?
Procter & Gamble stock has generated a significant amount of wealth for investors this year. The company boosted shareholders’ returns.
Why Church & Dwight Stock Is Underperforming Its Peers
Church & Dwight stock is lagging behind its peers by a wide margin so far this year. High valuation and moderating growth are to blame.
Why Colgate-Palmolive’s Q3 Earnings Failed to Impress
Colgate-Palmolive released its third-quarter earnings results today. The company’s performance was mixed, irking investors.
Why Church & Dwight Fell despite Its Q3 EPS Beat
Church & Dwight (CHD) stock was trading about 4% lower in morning trading after its third-quarter sales miss irked investors.
Church & Dwight Stock: Q3 Earnings Might Spur Growth
Most of the analysts maintained a neutral outlook on Church & Dwight stock before the third-quarter earnings announcement.
Procter Gamble: Q1 Earnings Could Drive Its Stock
Procter & Gamble (PG) is scheduled to announce its earnings for the first quarter of fiscal 2020 before the markets open on Tuesday.
Procter & Gamble Stock: Valuation Limits Upside
Procter & Gamble stock trades at 24.7x its fiscal 2020 estimated core EPS of $4.85. The stock trades at 23.2x its fiscal 2021 estimated core EPS of $5.17.
Church & Dwight Stock: Valuation Overshadows Growth
Church & Dwight (CHD) stock has risen 9.5% on a YTD (year-to-date) basis as of September 13. However, the stock lags its peers by a wide margin.
Procter & Gamble Stock: What’s behind Its Solid Return?
Procter & Gamble stock benefits from its strong organic sales. On average, the company’s organic sales have increased by 5% in the last four quarters.
Colgate-Palmolive’s Q2 EPS Met Estimates
Colgate-Palmolive (CL) announced its second-quarter results on July 26.
Church & Dwight Continues to Outperform with Its Earnings Growth
Church & Dwight’s (CHD) earnings have grown at a strong double-digit rate in the past several quarters and have outpaced those of its rivals. The company has surpassed Wall Street’s expectations in five out of the past six quarters.
Why Clorox Stock Is Underperforming Peers
Clorox stock (CLX) is down about 8% since the company posted its third quarter of fiscal 2019 earnings on May 1.
Q1 Beat and Improved Outlook Could Boost Church & Dwight Stock
Church & Dwight (CHD) has impressed with its better-than-expected first-quarter results and margin expansion.
Clorox Stock Drops 7.2% on Weak Quarterly Results
Clorox (CLX) stock fell 7.2% on May 1 following the company’s weaker-than-expected third-quarter results.
What’s on the Horizon for Colgate-Palmolive Stock?
Most of the analysts maintained a neutral stance on Colgate-Palmolive stock. Persistent challenges will likely limit the upside.
Procter & Gamble Posted Strong Sales in Q3
Procter & Gamble (PG) posted better-than-expected third-quarter sales. Procter & Gamble’s net sales of $16.5 billion beat analysts’ estimate.
Procter & Gamble Stock Fell despite Strong Q3 Results
Procter & Gamble posted impressive third-quarter results on April 23. Organic sales rose 5% due to stellar growth in the United States and China.
What Drove Kimberly-Clark’s Q1 Earnings?
Kimberly-Clark (KMB) posted better-than-expected earnings in the first quarter of 2019.
What’s behind Kimberly-Clark’s Strong Organic Sales?
Kimberly-Clark (KMB) posted better-than-expected first-quarter sales thanks to the strong growth in its base business.
Kimberly-Clark Stock Rose on Stronger-Than-Expected Q1 Results
Kimberly-Clark (KMB) stock rose 5.4% on April 22 after the company released stronger-than-expected first-quarter results.
Persisting Challenges Could Hurt Colgate-Palmolive in Q1
Colgate-Palmolive (CL) is scheduled to announce its first-quarter earnings results before the market opens on April 26.
What Analysts Suggest for PG Stock ahead of Its Q3 Results
The majority of analysts continue to suggest “holds” on Procter & Gamble (PG) stock.
What to Expect from Procter & Gamble’s Q3 2019 Results
Procter & Gamble (PG) is scheduled to announce its earnings results for the third quarter of fiscal 2019 before the market opens on April 23.
Is Kimberly-Clark Stock Heading for a Decline?
Kimberly-Clark (KMB) stock has increased 8.1% so far this year and trades at a forward PE multiple of 18.7x
Why Kimberly-Clark’s Sales Could Continue to Decline in Q1
Kimberly-Clark (KMB) has exceeded analysts’ sales estimate in the past two consecutive quarters.
Why Analysts Have a Bleak Outlook for Kimberly-Clark’s Q1
Kimberly-Clark (KMB) is expected to announce its first-quarter results before the markets open on Monday, April 22.
Where Clorox Stock Could Be Heading
Clorox stock is trading at a forward PE multiple of 24.1x, which looks unattractive given its projected growth rate of 6.3% for fiscal 2020.
Why JPMorgan Chase Has Downgraded Clorox Stock
The Clorox Company (CLX) stock fell ~1% on April 8 after JPMorgan Chase downgraded it to an “underweight” from a “neutral.”
Why Wells Fargo Upgraded Procter & Gamble Stock
Wells Fargo upgraded its rating on Procter & Gamble stock to “outperform” from “market perform” and raised its target price to $115 from $91 per share.
Church & Dwight Announces Acquisition, Stock Rises ~4%
On March 28, Church & Dwight (CHD) announced that it has agreed to acquire the FLAWLESS brand from Ideavillage for ~$900 million.
What’s Ahead For KMB and CL Stock?
Kimberly-Clark (KMB) and Colgate-Palmolive (CL) have been strong this year, driven by improved organic sales due to higher pricing.
Why Analysts Remain on Sidelines for CHD and CLX
The majority of analysts covering Church & Dwight (CHD) and Clorox (CLX) stock maintain a neutral outlook.
What’s Ahead for Church & Dwight and Clorox?
Church & Dwight (CHD) and Clorox (CLX) have underperformed peers so far this year.
What Analysts Recommend for PG, CL, CLX, KMB, and CHD Stock
Most analysts recommend “hold” for consumer packaged goods stocks.
What’s Ahead for PG, KMB, CL, CLX, and CHD Stock?
Most CPG (consumer packaged goods) manufacturers’ results impressed in the recent quarter, especially their sales.
Will Procter & Gamble Sustain Momentum in the Second Half?
Procter & Gamble (PG) has impressed with its financial performance in the first half of fiscal 2019 thanks to improved underlying sales.
Why the Uptrend in Colgate-Palmolive Stock Might Not Hold
Colgate-Palmolive stock has generated better returns than most of its peers so far this year and has outperformed the broader market.
Will Ongoing Challenges Limit the Upside in CL Stock?
Colgate-Palmolive (CL) reported better-than-expected fourth-quarter results on Friday, January 25.
Procter & Gamble Posted Strong Q2 Results, Stock Rose ~5%
On January 23, Procter & Gamble (PG) shares closed at 4.9%. The company posted impressive results for the second quarter of fiscal 2019.
Kimberly-Clark’s Earnings Miss Dragged Stock Down
Kimberly-Clark (KMB) posted mixed fourth-quarter results on January 23.
Will Colgate-Palmolive’s Q4 Results Stall the Recovery in Its Stock?
Colgate-Palmolive (CL) is expected to announce its fourth-quarter earnings results on January 25.
Procter & Gamble’s Valuation Compared to Its Peers
Procter & Gamble (PG) stock trades at 20.8x its estimated fiscal 2019 EPS of $4.41, which doesn’t look attractive.
Why Kimberly-Clark’s Q4 Revenues Are Expected to Decline
Kimberly-Clark (KMB) could continue to disappoint investors with its tepid sales performance at least in the foreseeable future.
How KMB Stock Could Perform ahead of Q4 Results
Kimberly-Clark (KMB) is scheduled to announce its fourth-quarter results on Wednesday, January 23.
Will Procter & Gamble’s Q2 Results Pressure Its Stock?
On January 23, Procter & Gamble (PG) is expected to announce its results for the second quarter of fiscal 2019.
What’s Backing the Uptrend in Hormel Foods Stock?
Hormel Foods (HRL) is another company in the consumer staples industry that has outperformed the broader markets so far this year.
Five Consumer Staples Stocks to Be Thankful For—Even This Year
So far, 2018 has been a difficult year for the consumer staples industry—even tougher than last year.
Church & Dwight Beats Q3 Estimates, but Outlook Could Hurt Stock
Church & Dwight (CHD) sustained its strong sales and earnings growth momentum and reported better-than-expected results for the third quarter.
Church & Dwight: Analysts Have a ‘Hold’ Recommendation
Church & Dwight (CHD) has outperformed its peers with its strong sales and earnings growth during the first half of 2018.
Will High Valuation Stall the Uptrend in CHD Stock?
Shares of Church & Dwight (CHD) are up 18.7% on a YTD (year-to-date) basis as of September 14, reflecting double-digit growth in the company’s top line over the past four quarters.
Church & Dwight Stock Sailing Smoothly, Peers Struggle
As most household and personal care product manufacturers struggle to increase sales, Church & Dwight (CHD) is sailing smoothly.
Kellogg, Kroger, and Church and Dwight: Sprouts of Green
Shares of the Kellogg Company (K), Kroger (KR), and Church and Dwight (CHD) have shown sharp recovery in recent months.
Kimberly-Clark’s Valuation Looks Cheap, but Challenges Persist
Kimberly-Clark (KMB) stock was trading at a forward PE multiple of 14.7x as of June 20.
Analysts’ Views on Colgate-Palmolive, Post-1Q18 Results
Numerous analysts covering Colgate-Palmolive (CL) stock decreased their target prices after the company’s 1Q18 results.
Here’s How Analysts Reacted to Kimberly-Clark’s 1Q18 Results
Kimberly-Clark’s gross margin fell significantly in 1Q18, which prompted a couple of analysts to lower the target price on Kimberly-Clark stock.
Kimberly-Clark Beat 1Q18 Estimates: No Respite for Stock
Kimberly-Clark (KMB) reported better-than-expected 1Q18 results on April 23, 2018.
What Analysts Suggest for Kimberly-Clark Stock?
Kimberly-Clark (KMB) is expected to sustain its sales momentum in 1Q18, thanks to anticipated growth in volumes.
Could Gillette’s Woes Mar Procter & Gamble Stock?
Procter & Gamble (PG) is expected to announce its fiscal 3Q18 earnings on April 20. Analysts expect PG to sustain its sales growth momentum.
What Analysts Say about Clorox Stock
Clorox’s (CLX) top line is expected to benefit from new product launches backed by innovation and efficient marketing.
Why Clorox Stock Fell Close to 7% after Its Fiscal 2Q18 Earnings
Clorox (CLX) stock fell ~7.0% on February 2 despite its mixed fiscal 2Q18 results and increased fiscal 2018 earnings guidance.
How Analysts Reacted to Colgate-Palmolive’s 4Q Earnings
Multiple analysts lowered their price target on Colgate-Palmolive (CL) stock following its 4Q17 earnings.
How Colgate-Palmolive Compares with Peers in Valuations
As of January 19, Colgate-Palmolive (CL) stock was trading at a forward PE multiple of 25.4x—about 12% higher than the peer group average of 22.7x.
What to Expect for Procter & Gamble’s Sales in Fiscal 2Q18
Procter & Gamble’s management remains upbeat and expects new product launches to drive its sales in fiscal 2018.
International Flavors & Fragrances’ Interest Coverage Ratio
International Flavors & Fragrances’ (IFF) increased debt has resulted in higher interest expense.
International Flavors & Fragrances: Is Rising Debt Good or Bad?
International Flavors & Fragrances’ (IFF) debt has reflected an upward trend in the past five years. At the end of 3Q17, it was reported at $1.6 billion.
How PG, KMB, CL, CLX, and CHD Compare on Valuation
As of November 24, 2017, Colgate-Palmolive (CL) stock was trading at a forward PE multiple of 24.0x, which is higher than its peers.
Why Analysts Remain Neutral on PG, KMB, CL, and CLX Stock
The majority of analysts providing recommendations on consumer product companies in the United States (SPY) continue to maintain a “neutral” outlook.
Why Analysts Maintain a Neutral Stance on CLX Stock
Most of the analysts providing the ratings on Clorox (CLX) maintain a neutral stance on the stock despite the company’s strong performance amid sluggish industry trends.
Kimberly-Clark’s Sales Missed Estimates, Obtained Growth
Kimberly-Clark’s (KMB) sales of $4.6 billion fell short of analysts’ estimate but returned to the growth trajectory.
Why Procter & Gamble Stock Fell after Its 1Q18 Earnings
Procter & Gamble reported mixed fiscal 1Q18 results. It topped analysts’ EPS estimate. However, sales remained shy of analysts’ consensus estimate.
Could Colgate-Palmolive Exceed Its 3Q17 Earnings Estimate?
Colgate-Palmolive (CL) is set to announce its 3Q17 earnings on Friday, October 27, 2017. Wall Street expects its adjusted EPS (earnings per share) to remain flat at $0.73.
Colgate-Palmolive Stock Could Rise More
Colgate-Palmolive (CL) stock has risen 14.5% on a YTD (year-to-date) basis as of October 11, 2017. The stock benefited from a few rating upgrades.
What Analysts Recommend for Colgate-Palmolive
The majority of analysts providing recommendations on Colgate-Palmolive (CL) stock maintain a neutral outlook.
How Procter & Gamble Is Performing on Profitability
Procter & Gamble (PG) has managed to report higher profitability despite waning sales.
Analyzing Procter & Gamble’s Sales
Procter & Gamble (PG) is struggling on the sales front. Moderating category growth in developed markets and lower pricing to beat the competition are taking a toll on its top-line performance.
Why Procter & Gamble Is under Pressure from Nelson Peltz
Procter & Gamble (PG) recently took a big blow when the company’s long-term investor Yacktman Asset Management openly supported activist investor Nelson Peltz.
Here’s Why Clorox Is Outperforming Peers
Amid weak demand and increased competitive activity, the Clorox Company (CLX) has been consistent with its performance in the past one year and has reported industry-leading sales growth.
What Drove Procter and Gamble’s Fiscal 4Q17 Earnings Beat
Procter and Gamble (PG) reported better-than-expected fiscal 4Q17 earnings on Thursday, July 27.
Kimberly-Clark’s 2Q Sales Miss Estimate: Blame Developed Markets
Kimberly-Clark’s (KMB) 2Q17 sales of $4.6 billion missed analysts’ estimate and fell 0.70% YoY. Lower sales in developed markets are to blame.
Analysts Remain ‘Neutral’ on Colgate-Palmolive Stock after 2Q17
Analysts are maintaining a consensus score of 2.8 on CL stock on a scale of 1.0 (“strong buy”) to 5.0 (“strong sell”).
Kimberly-Clark: Analysts’ Recommendations and Target Price
Most analysts covering Kimberly-Clark maintain a “neutral” outlook on the stock. It’s expected to report muted sales growth in upcoming quarters.